Eli Lilly LLY announced that it has entered into a definitive agreement to acquire U.K.-based Centessa Pharmaceuticals CNTA.

Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of ...

IBT's Ailsa Craig and Marek Poszepczynski give their key stock picks as companies move on from the science to commercial ...

The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...

Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...

Lipella Pharmaceuticals, a biotechnology company in Pittsburgh’s Homewood neighborhood, filed for bankruptcy protection ...

As foundational AI models muscle into biosciences and pharmaceuticals, what does it mean for India's $55-billion ...

PSC Biotech partners with Blue Ocean Robotics to distribute the UVD Robot Pharma delivering autonomous UV C disinfection for ...

US drugmaker Eli Lilly has signed a $2bn deal with a Hong Kong-listed company that uses AI for drug discovery, highlighting ...

The Swiss pharma giant is betting on a next-generation allergy treatment that may prove to work faster and better than ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...